Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ehmann

Showing results (641-650 of 645) with videos related to

Pageof 65
Sort By:
You have reached the last page of results.This site can display upto 645 results.
Nature Microbiology|July 1, 2017
ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumanniiThomas F Durand-Réville, Satenig Guler, Janelle Comita-Prevoir, et al.
Human Gene Therapy|December 29, 2025
Intravenous Delivery of a Gene Therapy Vector that Expresses an Antitransferrin Receptor 1 Nanobody-I2S Fusion Protein Rescued Central Nervous System Lysosomal Burden in Mucopolysaccharidosis II MiceWanida Ruangsiriluk, Sarah Melissa P Jacobo, Andrea Iskenderian, et al.
Chest|September 29, 2020
Operational Recommendations for Scarce Resource Allocation in a Public Health CrisisMichael R Ehmann, Elizabeth K Zink, Amanda B Levin, et al.
The Journal of Clinical Investigation|June 25, 2024
Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in miceNana Talvard-Balland, Lukas M Braun, Karen O Dixon, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Divergent T Cell Phenotypes Define Pediatric Crohn's Disease and Ulcerative ColitisLeonard Nettey, Hengqi Betty Zheng, Joseph C Devlin, et al.
Pageof 65

Showing results (641-650 of 645) with videos related to

Sort By:
Pageof 65
You have reached the last page of results.This site can display upto 645 results.
Nature Microbiology|July 1, 2017
ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumanniiThomas F Durand-Réville, Satenig Guler, Janelle Comita-Prevoir, et al.
Human Gene Therapy|December 29, 2025
Intravenous Delivery of a Gene Therapy Vector that Expresses an Antitransferrin Receptor 1 Nanobody-I2S Fusion Protein Rescued Central Nervous System Lysosomal Burden in Mucopolysaccharidosis II MiceWanida Ruangsiriluk, Sarah Melissa P Jacobo, Andrea Iskenderian, et al.
Chest|September 29, 2020
Operational Recommendations for Scarce Resource Allocation in a Public Health CrisisMichael R Ehmann, Elizabeth K Zink, Amanda B Levin, et al.
The Journal of Clinical Investigation|June 25, 2024
Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in miceNana Talvard-Balland, Lukas M Braun, Karen O Dixon, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Divergent T Cell Phenotypes Define Pediatric Crohn's Disease and Ulcerative ColitisLeonard Nettey, Hengqi Betty Zheng, Joseph C Devlin, et al.
Pageof 65